Filter
1246
Filtered Results: 1246
Text search:
drug
shortage
Featured
Recommendations
100
New Publications
425
Language
Document type
No document type
802
Studies & Reports
213
Guidelines
111
Strategic & Response Plan
48
Manuals
40
Training Material
12
Situation Updates
9
Fact sheets
7
Infographics
2
Resource Platforms
1
Online Courses
1
Countries / Regions
India
51
Ethiopia
47
Kenya
44
Uganda
40
Liberia
40
Sierra Leone
37
Malawi
36
South Africa
36
Western and Central Europe
35
Nigeria
30
Global
30
Tanzania
29
Myanmar / Burma
29
Zambia
28
Bangladesh
22
Ghana
21
Ukraine
18
Zimbabwe
18
Latin America and the Carribbean
18
Nepal
17
Lesotho
17
Africa
17
Namibia
17
Eastern Europe
15
Syria
14
Cambodia
14
Asia
14
Rwanda
12
Mozambique
12
Botswana
12
South–East Asia Region
10
Burkina Faso
8
Philippines
8
Haiti
7
Venezuela
7
South Sudan
7
Senegal
6
Guinea
6
Eastern Europe and Central Asia
6
Indonesia
6
Cameroon
5
Albania
5
Colombia
4
Thailand
4
Germany
4
Middle East and North Africa
4
East and Southern Africa
4
Vietnam
4
North Macedonia
3
Tajikistan
3
Benin
3
Laos
3
West and Central Africa
3
Brazil
3
Moldova
3
Russia
3
Yemen
3
Eswatini/ Swaziland
3
Pakistan
3
Mexico
2
Turkey
2
Afghanistan
2
USA
2
Jordan
2
Congo, Democratic Republic of
2
United Kingdom
2
Lebanon
2
Palestine
2
Libya
2
El Salvador
1
China
1
Chile
1
Fiji
1
Estonia
1
Peru
1
Bulgaria
1
Italy
1
Hungary
1
Lithuania
1
France
1
Maldives
1
Mauritius
1
Portugal
1
Spain
1
Belarus
1
Southern Africa
1
Bolivia
1
Argentina
1
Papua New Guinea
1
Sri Lanka
1
Central African Republic
1
Poland
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
609
Clinical Guidelines
75
Public Health
62
Women & Child Health
38
Key Resources
27
Capacity Building
15
Pharmacy & Technologies
12
Toolboxes
HIV
98
TB
91
COVID-19
81
Mental Health
80
AMR
58
Pharmacy
35
Conflict
27
Caregiver
25
NCDs
24
Planetary Health
21
Disability
18
Ebola
18
NTDs
17
Global Health Education
16
Rapid Response
14
Refugee
13
Natural Hazards
10
Cholera
7
Health Financing Toolbox
6
Polio
5
Specific Hazards
3
Social Ethics
2
Zika
2
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri...
This new guidance aims to support programme implementers, coordinators and others in humanitarian settings in their actions to counter suicide and self-harm in humanitarian contexts and to save lives.
Trachoma causes more vision loss and blindness than any other infection in the world. This disease is caused by Chlamydia trachomatis bacteria. Other variants or strains of these bacteria can cause a sexually transmitted infection (chlamydia) and disease in lymph nodes.
This is photomicrograph ...
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out health interventions in emergency and humanitarian r...
Access to health workers who are fit for purpose, motivated and protected is a fundamental force of health service delivery and the achievement of universal health coverage and the health and health-related Sustainable Development Goals. Data and knowledge of the distribution, skill mix and future d...
Female Genital Schistosomiasis (FGS) is a gynaecological disease caused by Schistosoma haematobium, a parasitic worm that is acquired by skin contact with freshwater contaminated by schistosome cerceriae. Communities in which the infection is most endemic have limited access to clean water and healt...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan...
Since the beginning of the Ukraine crisis on 24 February 2022, WHO has supported Government-led efforts and initiatives alongside key partners on the ground. Building on efforts to date, and working alongside Bulgaria’s health authorities to bring added value to existing mechanisms, the WHO Countr...
The NDMS&IP focuses on mainstreaming disability to promote equitable access to services in the six thematic areas of health, education, livelihoods, empowerment, and social inclusion and cross-cutting issues.
The first part of the NDMS&IP outlines incongruences between national and sectoral policie...
The availability of controlled medicines is crucial for patients requiring palliative care, pain relief and symptom management. Many individuals worldwide, especially in low- and middle-income countries, continue to experience limited access to these essential medicines. Enhancing access to controll...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i...
The Country Cooperation Strategy is the World Health Organization’s corporate framework developed in response to a country’s needs and priorities. The 2022–2025 CCS is the fourth for WHO in Sierra Leone. It is a medium-term strategic document that defines a broad framework for WHO’s work, at...
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (...
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detection and management of cardiovascular diseases and provide a generic global framework available for loca...
The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare costs. Roadmaps provide a blueprint for implementation of priority solutions for the principal cardiovascular diseases leading to death...
Many low- and middle-income countries (LMICs) are undergoing an epidemiological transition. With an improvement in socioeconomic conditions and an aging population, cardiovascular diseases (CVDs), like cardiac arrhythmias, are expected to increase in these countries. However, there are limited studi...
Cholera is a transmissible diarrhoeal infection caused by Vibrio cholerae. Endemic and/or epidemic in over 40 countries (mainly in Africa and Asia), cholera continues to be a major global public health issue.
The World Health Organization (WHO) estimates that the number of cases reported worldwid...
A major problem facing the world is how to build peace following the ravages of increasingly protracted armed conflict. Armed conflicts leave behind shattered, divided societies that are at risk of repeating cycles of violence, and therefore need concerted peacebuilding efforts. Conflicts also take ...
